Evidence map›Paper›PMID 40998814›Full record

ArticleScientific reports2025

Theoretical studies of arbutin, glutathione, and sea cucumber extracts as inhibitors of tyrosinase.

Zheng Zheng, Shizhuo Zhang, Tao Jiang, Wenlang Liu, Zifan Xu, Xinyi Shen, Tiantian Sun

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Zheng ZhengWuhan University of Technology, Wuhan, 430070, Hubei, People's Republic of China. johnzhengzz@whut.edu.cn.
Shizhuo ZhangWuhan University of Technology, Wuhan, 430070, Hubei, People's Republic of China.
Tao JiangDivamics Inc., Suzhou, 215000, People's Republic of China.
Wenlang LiuDivamics Inc., Suzhou, 215000, People's Republic of China.
Zifan XuDivamics Inc., Suzhou, 215000, People's Republic of China.
Xinyi ShenDivamics Inc., Suzhou, 215000, People's Republic of China.
Tiantian SunDivamics Inc., Suzhou, 215000, People's Republic of China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tyrosinase is a crucial enzyme targeted for the development of various skin-whitening agents due to its role in regulating key steps in melanin production. Despite the significance of human tyrosinase (hTYR), its crystal structure remains unresolved, hindering the development of specific inhibitors. Researchers frequently use mushroom tyrosinase (mTYR) to evaluate the inhibition capabilities of compounds, but the structural differences between hTYR and mTYR present considerable challenges in accurately developing hTYR-specific inhibitors. For instance, compounds like kojic acid show promising inhibitory effects but face limitations due to cytotoxicity or allergic reactions. This study aims to utilize the AlphaFold-predicted structure of hTYR to provide insights for developing specific inhibitors by comparing it with mTYR. We utilized natural tyrosinase inhibitors reported in the literature for molecular docking and molecular dynamic simulations to examine their binding modes with mTYR and hTYR. Through the analysis of these binding interactions and dynamic behaviors, we intend to identify residues that significantly enhance affinity, assess reliable binding modes, and offer essential insights for the development of effective hTYR inhibitors.

Indexed as

ArbutinEnzyme InhibitorsGlutathioneMonophenol MonooxygenaseAgaricalesAnimalsBinding SitesHumansMolecular Docking SimulationMolecular Dynamics SimulationProtein BindingArbutinEnzyme InhibitorsGlutathioneMonophenol MonooxygenaseHuman tyrosinase inhibitorsMolecular DockingMolecular dynamicsNatural inhibitors

Identifiers

PMID40998814
PMCPMC12464207

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.